REN Pharmaceuticals Obtains $1,500,000 New Financing

  • Feed Type
  • Date
  • Company Name
    REN Pharmaceuticals
  • Mailing Address
    270 E. Grand Ave. South San Francisco, CA 94080
  • Company Description
    The company’s mission is to develop and commercialize breakthrough therapeutics for renal diseases and associated cardio-renal diseases.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Sanderling Ventures

By posting a comment, you agree to our terms and conditions.